Viewing Study NCT00102466


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2025-12-25 @ 3:51 PM
Study NCT ID: NCT00102466
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2005-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module